GlassScriptPhysician profile
Joseph Robert Larson
NPI 1710335872
$2,923.08
in general payments reported to CMS, 2019-2025
8 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $240 · 2021: $729 · 2022: $1,247 · 2023: $231 · 2024: $314 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $272 · Honoraria: $19.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $272.08 |
| Honoraria | $19.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Benco Dental Supply Co. | $1,108.04 | 2022-2023 | |
| Straumann USA LLC | $781.73 | 2022-2025 | |
| Stryker Corporation | $691.05 | 2021 | |
| Medical Device Business Services, INC. | $240.00 | 2020 | |
| Biohorizons Implant Systems INC. | $37.54 | 2021 | |
| Nobel Biocare USA | $30.17 | 2023 | Nobelactive |
| Vertex Pharmaceuticals Incorporated | $19.32 | 2025 | |
| Dentsply Sirona INC | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.